Sign in

CIK 0001999480

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Alto Neuroscience, Inc.

Sign in to watch
Ticker
ANRO
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
834210124
Phone
+1 773-255-5012
Business address
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
  1. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 6,150 shares at an average $16.36 ($100,628)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Conversion See Remarks acquired 926,539 shares (conversion)
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 19,153 shares (grant or award)
  7. 4 Grant or award PRESIDENT AND CEO acquired 34,711 shares (grant or award)
  8. 4 Open-market buy 10% owner bought 600,000 shares at $16.00 ($9,600,000)
  9. 4 Conversion Director acquired 23,917 shares (conversion)
  10. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 1,563 shares at $16.00 ($25,008)
  11. 4 Conversion Director acquired 715,653 shares (conversion)
  12. 4 Open-market buy CHIEF MEDICAL OFFICER bought 17,000 shares at $16.00 ($272,000)
  13. 4 Open-market buy PRESIDENT AND CEO bought 3,125 shares at $16.00 ($50,000)
  14. 4 Conversion Director acquired 47,709 shares (conversion)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 3 of 4 · 70 filings